WNK2 and osteoporosis: The anti-osteoporosis effects have been attributed to arecoline, which has been shown to inhibit the downstream transcription factors nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases activated by RANKL–RANK interactions [16,24].